vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and LiveRamp Holdings, Inc. (RAMP). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $212.2M, roughly 1.3× LiveRamp Holdings, Inc.). LiveRamp Holdings, Inc. runs the higher net margin — 18.8% vs 0.7%, a 18.1% gap on every dollar of revenue. On growth, LiveRamp Holdings, Inc. posted the faster year-over-year revenue change (8.6% vs -16.5%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
LiveRamp Holdings, Inc., is an American SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
HCM vs RAMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $212.2M |
| Net Profit | $2.0M | $39.9M |
| Gross Margin | 37.7% | 71.9% |
| Operating Margin | -13.2% | 18.6% |
| Net Margin | 0.7% | 18.8% |
| Revenue YoY | -16.5% | 8.6% |
| Net Profit YoY | -83.6% | 255.7% |
| EPS (diluted) | $0.00 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $212.2M | ||
| Q3 25 | — | $199.8M | ||
| Q2 25 | $277.7M | $194.8M | ||
| Q1 25 | $324.5M | $188.7M | ||
| Q4 24 | — | $195.4M | ||
| Q3 24 | — | $185.5M | ||
| Q2 24 | $305.7M | $176.0M | ||
| Q1 24 | — | $171.9M |
| Q4 25 | $2.0M | $39.9M | ||
| Q3 25 | — | $27.4M | ||
| Q2 25 | $455.0M | $7.7M | ||
| Q1 25 | $11.9M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $25.8M | $-7.5M | ||
| Q1 24 | — | $-5.4M |
| Q4 25 | 37.7% | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | 0.1% | 70.1% | ||
| Q1 25 | 48.0% | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | 41.1% | 70.6% | ||
| Q1 24 | — | 72.2% |
| Q4 25 | -13.2% | 18.6% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | -1.3% | 3.7% | ||
| Q1 25 | -5.0% | -6.1% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | -9.0% | -3.0% | ||
| Q1 24 | — | -8.3% |
| Q4 25 | 0.7% | 18.8% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | 163.8% | 4.0% | ||
| Q1 25 | 3.7% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | 8.4% | -4.3% | ||
| Q1 24 | — | -3.1% |
| Q4 25 | $0.00 | $0.62 | ||
| Q3 25 | — | $0.42 | ||
| Q2 25 | $0.52 | $0.12 | ||
| Q1 25 | $0.01 | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | $0.03 | $-0.11 | ||
| Q1 24 | — | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $403.4M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $962.3M |
| Total Assets | $1.8B | $1.3B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $403.4M | ||
| Q3 25 | — | $376.9M | ||
| Q2 25 | $1.4B | $371.1M | ||
| Q1 25 | $836.1M | $420.8M | ||
| Q4 24 | — | $384.3M | ||
| Q3 24 | — | $348.4M | ||
| Q2 24 | $802.5M | $342.7M | ||
| Q1 24 | — | $368.9M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $962.3M | ||
| Q3 25 | — | $943.8M | ||
| Q2 25 | $1.2B | $947.8M | ||
| Q1 25 | $759.9M | $948.9M | ||
| Q4 24 | — | $957.7M | ||
| Q3 24 | — | $932.1M | ||
| Q2 24 | $740.1M | $951.9M | ||
| Q1 24 | — | $949.1M |
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | — | ||
| Q3 25 | — | $57.4M | ||
| Q2 25 | $-72.9M | $-15.8M | ||
| Q1 25 | $40.3M | — | ||
| Q4 24 | — | $45.1M | ||
| Q3 24 | — | $55.6M | ||
| Q2 24 | $-39.8M | $-9.3M | ||
| Q1 24 | — | — |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | $-82.2M | $-16.2M | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | — | $55.4M | ||
| Q2 24 | $-49.9M | $-9.6M | ||
| Q1 24 | — | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | -29.6% | -8.3% | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | -16.3% | -5.4% | ||
| Q1 24 | — | — |
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | 3.3% | 0.2% | ||
| Q1 25 | 2.4% | 0.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | -0.16× | -2.04× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
